Enso Ventures
Enso Ventures is a Venture Capital firm that was founded in 2010 and based in London with an additional office in New York. The firm is looking to provide equity capital to high growth companies in the life science space. The firm is currently interested in companies located in Europe, Russia and the US and is looking to make approximately 2-3 investments over the next 6-9 months.
Sergei Petukhov
PartnerExcel Venture Management
Excel Venture Management is a venture capital firm that was founded in 2008 and is based in Boston, Massachusetts. The firm has managed one fund with committed capital of $125 million, and the firm is currently raising the second fund. Excel Venture Management seeks to make equity investments into life science companies from early to late stages. The typical investment size ranges from $3 million to $ 5million. The firm plans to invest in 4-5 companies over the next 6-9 months and prefers to invest in companies based in US.
Eric Zimmerman
Kevin Liang
Flagship Ventures
David Berry
PartnerFoundation Fighting Blindness
Tom Capetan
Business DevelopmentGenrich
John Nelson
Managing DirectorGolden Seeds
Bill Whitaker
Managing Director Co-Chair Life Science SectionGordian Biotechnologies Inc.
Gordian Biotechnologies addressing the urgent unmet medical existing within antibiotic resistance by developing first-in-class reversible b-lactamase inhibitors that allow existing antibiotics to be effective against otherwise resistant pathogens. By combining an FDA approved antibiotic with our novel b-lactamase inhibitors, Gordian Biotechnologies disarms the bacteria’s resistance mechanism, allowing the antibiotic to defeat the pathogen.
H.I.G. BioVentures
Enoch Kariuki
Vice PresidentHercules Technology Growth Capital Inc.
Janice Borque
Managing Director Life SciencesHorizon Technology Finance
Horizon Technology Finance is a venture lending, investment and financial services management company that was founded in 2003 and is headquartered in Farmington, Ct with additional offices in Walnut Creek, CA and Reston, VA. The firm controls approximately $200 million in assets under management and look to provide senior or subordinate loans to companies in the range of $2 to $20 million dollars, and often syndicates much larger deals. The firm prefers to lead or co-lead investments that they are involved in and looks to be involved in 15 deals in the next 6-9 months. The firm provides capital to companies located throughout the United States and Canada.